QR-Code

Cost drivers in the pharmacological treatment of interstitial lung disease

Abstract Introduction Treatments of interstitial lung diseases (ILDs) mainly focus on disease stabilization and relief of symptoms by managing inflammation or suppressing fibrosis by (in part costly) drugs. To highlight economic burden of drug treatment in different ILD-subtypes we assessed cost tre...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Phillen Nozibuyiso Maqhuzu, Michael Kreuter, Thomas Bahmer, Nicolas Kahn, Martin Claussen, Rolf Holle, Larissa Schwarzkopf
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2021-08-01
Schriftenreihe:Respiratory Research
Schlagworte:
Diffuse parenchymal lung disease
Healthcare expenditure
Direct costs
ILD management
Healthcare spending
Online-Zugang:https://doi.org/10.1186/s12931-021-01807-8
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge